Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Archives of Gynecology and Obstetrics|March 23, 2000
A study of fetal macrosomiaK Wollschlaeger, J Nieder, I Köppe, et al.
Gynecologic Oncology|January 6, 2000
Acute problems during low-dose-rate intracavitary brachytherapy for cervical carcinomaK Wollschlaeger, P P Connell, S Waggoner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2005
Non-enrolment of ovarian cancer patients in clinical trials: reasons and backgroundP Harter, A du Bois, C Schade-Brittinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 29, 2006
The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVARJ Pfisterer, A du Bois, J Sehouli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2012
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapyK H Baumann, A du Bois, W Meier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.
British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.
Pageof 1